###begin article-title 0
###xml 28 29 24 25 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 33 34 26 27 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
Expression of Integrin alphavbeta3 in Gliomas Correlates with Tumor Grade and Is not Restricted to Tumor Vasculature
###end article-title 0
###begin p 1
Both authors contributed equally
###end p 1
###begin p 2
Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation.
###end p 2
###begin p 3
###xml 204 205 200 201 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 209 210 202 203 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 308 309 297 298 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 313 314 299 300 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 470 471 452 453 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 475 476 454 455 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 548 549 523 524 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 553 554 525 526 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 824 825 792 793 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 829 830 794 795 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1025 1026 987 988 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1130 1131 1088 1089 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 1135 1136 1090 1091 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1205 1206 1156 1157 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 1210 1211 1158 1159 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
In malignant gliomas, the integrin adhesion receptors seem to play a key role for invasive growth and angiogenesis. However, there is still a controversy about the expression and the distribution of alphavbeta3 integrin caused by malignancy. The aim of our study was to assess the extent and pattern of alphavbeta3 integrin expression within primary glioblastomas (GBMs) compared with low-grade gliomas (LGGs). Tumor samples were immunostained for the detection of alphavbeta3 integrin and quantified by an imaging software. The expression of alphavbeta3 was found to be significantly higher in GBMs than in LGGs, whereby focal strong reactivity was restricted to GBMs only. Subsequent analysis revealed that not only endothelial cells but also, to a large extent, glial tumor cells contribute to the overall amount of alphavbeta3 integrin in the tumors. To further analyze the integrin subunits, Western blots from histologic sections were performed, which demonstrated a significant difference in the expression of the beta3 integrin subunit between GBMs and LGGs. The presented data lead to new insights in the pattern of alphavbeta3 integrin in gliomas and are of relevance for the inhibition of alphavbeta3 integrin with specific RGD peptides and interfering drugs to reduce angiogenesis and tumor growth.
###end p 3
###begin title 4
INTRODUCTION
###end title 4
###begin p 5
###xml 318 320 318 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">25</xref>
###xml 322 324 322 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26">26</xref>
###xml 326 328 326 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b34">34</xref>
###xml 493 495 493 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">14</xref>
###xml 497 499 497 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b40">40</xref>
###xml 734 736 734 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23">23</xref>
###xml 738 740 738 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b36">36</xref>
###xml 904 905 897 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 907 909 900 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23">23</xref>
###xml 911 913 904 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b41">41</xref>
###xml 1197 1199 1190 1192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">13</xref>
###xml 1201 1203 1194 1196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b41">41</xref>
Gliomas are the most common brain-derived neoplasms with glioblastoma (GBM) multiforme being the most frequent and also the most malignant subtype. Marked tumor cell proliferation, rapid invasion into the surrounding brain tissue and intense microvascular angiogenesis are the biologic hallmarks of malignant gliomas (25, 26, 34). They depend on the complex interactions of tumor cells with the extracellular matrix (ECM) and neighboring endothelial cells as well as various other cell types (14, 40). These mechanisms include signaling via integrins, which are involved in adhesive properties of proliferating cells and play fundamental roles in the regulation of migration and invasion of tumor cells as well as of neoangiogenesis (23, 36). The integrin family consists of 24 different heterodimeric receptors of two transmembrane subunits of which the 18alpha and 8beta subunits are known at present (5, 23, 41). In contrast to many other cell-surface receptors, integrins are not only able to transduce signals to the interior of the cells ("outside-in" signaling) but can also transmit information about the activational state of the cells to their microenvironment ("inside-out" signaling) (13, 41).
###end p 5
###begin p 6
###xml 19 20 15 16 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 24 25 17 18 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 35 36 24 25 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 40 41 26 27 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 254 255 232 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">9</xref>
###xml 257 259 235 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b10">10</xref>
###xml 261 263 239 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 288 289 262 263 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 293 294 264 265 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 486 488 457 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">16</xref>
###xml 632 633 599 600 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 637 638 601 602 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 704 706 668 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32">32</xref>
###xml 723 724 683 684 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 728 729 685 686 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 844 845 801 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
###xml 847 849 804 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b11">11</xref>
###xml 875 876 828 829 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 880 881 830 831 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1031 1032 977 978 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 1036 1037 979 980 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1319 1320 1258 1259 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 1324 1325 1260 1261 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 559 567 <span type="species:ncbi:9606">patients</span>
###xml 1103 1111 <span type="species:ncbi:9606">patients</span>
The integrins alphavbeta3 and alphavbeta5 have been demonstrated to be necessary for tumor-induced angiogenesis in a variety of tumors, particularly malignant gliomas via basic fibroblast growth factor (bFGF) and tumor necrosis factor alpha (TNF-alpha) (9, 10, 15). Indeed, integrin alphavbeta3 has been found to be located in small blood vessels in GBMs, where it is thought to promote the extensive tumor progression, while in the tissue of the normal brain, it is barely detectable (16). Interestingly, immunohistochemical studies of autopsy material from patients with brain tumors revealed that the expression of integrin alphavbeta3 might not be restricted only to proliferating endothelial cells (32). Integrin alphavbeta3 was also detected and colocalized with matrix metalloproteinase 2 (MMP-2) at the surface of invasive tumor cells (6, 11). Yet, the level of alphavbeta3 integrin expression and its cellular distribution caused by malignancy has not been expounded up to now. This has become even more important as alphavbeta3 integrin antagonists have reached phase I/IIa clinical trials in patients with malignant gliomas, where they are used in combination with temozolomide as an antiangiogenic therapy. The current study was undertaken to elucidate the expression level and pattern of the integrin alphavbeta3 in high- and low-grade gliomas (LGGs) by analysis of snap-frozen tumor samples.
###end p 6
###begin title 7
MATERIALS AND METHODS
###end title 7
###begin title 8
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients and tissue samples
###end title 8
###begin p 9
###xml 361 363 361 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">25</xref>
###xml 411 412 407 408 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 416 417 409 410 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 226 234 <span type="species:ncbi:9606">patients</span>
The brain tissues were obtained from 20 primary GBMs, corresponding to the World Health Organization (WHO) grade IV, and five diffuse astrocytomas, corresponding to WHO grade II. Written informed consent was obtained from all patients for the scientific use of tumor tissue. The histologic diagnosis was made on paraffin sections according to the WHO criteria (25). For the immunohistochemical analysis of alphavbeta3 integrin expression (GBM: n = 12; LGG: n = 4; histologically suitable quality) and Western blot analysis (GBM: n = 20; LGG: n = 5), corresponding tissue samples were snap frozen in liquid nitrogen and processed as described below. Additionally, samples of five different solid peripheral tumors (malignant melanoma, neurofibroma, skin cancer metastases, malignant fibrillary histiocytoma and sarcoma; n = 1 each) were processed (kindly provided by the Department of Pathology, Technical University of Munich, Munich, Germany).
###end p 9
###begin title 10
Histologic and immunohistochemical staining
###end title 10
###begin title 11
Paraffin sections
###end title 11
###begin p 12
###xml 51 59 <span type="species:ncbi:9606">patients</span>
For the histologic tumor grading, tissues from all patients were fixed for at least 24 h in phosphate-buffered formalin (4%, pH 7.3), dehydrated in graded ethanol followed by xylol and embedded in hot paraffin. Sections (6 microm) were cut from a cold paraffin block and mounted on slides. After drying and deparaffination in graded alcohol, routinely Hematoxilin & Eosin (H&E), Elastica van Gieson and Gomorri stains were performed. Additional immunohistochemical investigations included the proliferation index by staining proliferation marker MIB-1 and glial fibrillary acid protein (GFAP) according to standard procedures (antibodies were obtained from DakoCytomation, Hamburg, Germany).
###end p 12
###begin title 13
Cryosections
###end title 13
###begin p 14
###xml 723 724 707 708 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 728 729 709 710 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
Cryosections of 6-microm thickness (GBM: n = 12; LGG: n = 4; histologically suitable quality) were mounted on glass slides (Superfrost Plus, Menzel, Braunschweig, Germany) and postfixed with 4% paraformaldehyde and acetone (each 10 minutes at 4degreesC). After a short equilibration in phosphate-buffered saline (pH 7.3) over 10 minutes at room temperature, immunohistochemical stains were performed simultaneously and automatically to reach a maximum of accuracy (BenchMark(R) and software NexES v9.20, Ventana, Strasbourg, France). As primary antibodies, we used either polyclonal anti-GFAP (1:1600, DakoCytomation, Hamburg, Germany), monoclonal anti-CD31 (1:50, DakoCytomation, Hamburg, Germany) or monoclonal anti-alphavbeta3 integrin (1:100, clone LM609, Chemicon, Temecula, CA, USA) diluted in antibody diluent (Antibody Diluent, Ventana, Strasbourg, France). The primary antibody was incubated over 32 minutes at 37degreesC (software: "option 1 per hand"). Respective application of polyclonal biotinylated secondary antibodies (1:150, DakoCytomation, Hamburg, Germany, secondary antibody incubation 32 minutes at 37degreesC, software: "option 2 by dispenser") was followed by alkaline phosphatase conjugated streptavidin (enhanced SA-AP over 12 minutes, Ventana, Strasbourg, France). Visualization was achieved by the generation of Fast Red over 20 minutes at room temperature as prescribed by the manufacturer (enhancer/naphthol 4 minutes, Fast Red A 8 minutes, Fast Red B 8 minutes, Ventana, Strasbourg, France). Subsequently, the slides were counterstained with hematoxylin (hematoxylin 4 minutes, bluing reagent 4 minutes) and 4'-6-Diamidino-2-phenylindole (DAPI). The slides were dehydrated by an ascending ethanol sequence (50%, 70%, 98%, 100%) and xylene, and finally covered.
###end p 14
###begin p 15
###xml 228 229 224 225 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 233 234 226 227 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 432 433 421 422 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 437 438 423 424 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 391 396 <span type="species:ncbi:9606">human</span>
All immunohistochemical staining procedures and antibody concentrations were adjusted to avoid overstaining (saturation), understaining (beyond detection limit) or non-specific background artifacts. In detail, for staining alphavbeta3 integrin, series of dilutions of the secondary antibody (previous incubation without primary antibody) were performed on positive control (xenotransplanted human M21 melanoma cells expressing alphavbeta3, see below) to determine the highest concentration where no background artifacts or non-specific binding occurred (= maximum sensitivity of secondary detection). Then, based on this setting, series of the primary antibody concentration were tested on the positive control. As staining intensity demonstrates a saturation effect, the concentration developing a moderate staining intensity (about half of the maximum intensity of a blank sample) was further used. At this concentration, no non-specific background staining was detectable.
###end p 15
###begin title 16
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
Murine tumor models
###end title 16
###begin p 17
###xml 60 61 56 57 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 65 66 58 59 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 77 79 70 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">12</xref>
###xml 81 83 74 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19">19</xref>
###xml 203 205 196 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20">20</xref>
###xml 17 22 <span type="species:ncbi:9606">human</span>
Xenotransplanted human melanoma cells (M21) expressing alphavbeta3 integrin (12, 19) served as a positive immunohistochemical control. Cell culture conditions for M21 were set up as described elsewhere (20). The experimental protocol involving animals was approved by the Committee of Veterinarian Medicine of the State of Bavaria; the handling of animals was performed according to the standards set by the Committee of Veterinarian Medicine.
###end p 17
###begin p 18
###xml 59 60 59 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 268 270 268 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20">20</xref>
###xml 32 36 <span type="species:ncbi:10090">mice</span>
To obtain the tumor tissue, the mice were injected 1.5 x 106 M21 subcutaneously, which led to the formation of tumors with a diameter of approximately 8 mm within 8 weeks. Four weeks after inoculation, the tumors were dissected, cut and frozen for further processing (20).
###end p 18
###begin title 19
Analysis of immunohistochemical staining
###end title 19
###begin p 20
###xml 42 43 38 39 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 47 48 40 41 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 394 396 387 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b33">33</xref>
The immunohistochemical detection of alphavbeta3 integrin was determined by a special imaging software, which was calibrated for this purpose. Within a selected area, it measured (i) the mean intensity of the desired immunohistochemical staining and (ii) the immunohistochemically positive fraction at a desired immunohistochemical staining intensity (software written by the author B. Krebs) (33).
###end p 20
###begin p 21
###xml 871 872 863 864 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 876 877 865 866 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 929 931 918 920 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">12</xref>
###xml 933 935 922 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19">19</xref>
###xml 1097 1098 1082 1083 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 1102 1103 1084 1085 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 830 835 <span type="species:ncbi:9606">human</span>
In detail, all sections stained in parallel were scanned through an upright microscope (Axiovert 200M and Axiocam MRc5, Carl Zeiss AG, Jena, Germany), keeping the settings including light intensity constant. In the digitized pictures (983 x 737 microm), the area of tissue was selected by excluding possible empty areas of glass light only. Consequently, the measurement was related to tissue only. Then, the selected area was scanned for immunohistochemical detection. Thereby, the software mathematically extracted the component of the desired immunohistochemical staining per pixel (Fast Red maximum emission: 580 nm) and determined its intensity. From this data, the mean intensity of the immunohistochemical staining was calculated. For calibrating the intensity measurement, a sample stained in parallel of xenotransplanted human M21 melanoma cells expressing alphavbeta3 was used. This sample acted as a positive control (12, 19) and was set to 100%. The tissue that was counterstained only served as a negative control (set to 0%). The procedure resulted in (i) the relative level of alphavbeta3 integrin expression in the respective sample (= mean immunohistochemical staining intensity). In addition, to evaluate the distribution pattern of the immunohistochemical staining intensity within the selected area, the fraction of immunohistochemically positive area at a desired intensity level was calculated. In this study, three different levels of staining intensity defined as mild, moderate or strong (about 25%, 50% and 75% of positive control) were investigated. This resulted in (ii) a quantification based on the desired levels of staining intensity (= fraction at different intensity levels).
###end p 21
###begin title 22
Western blot
###end title 22
###begin p 23
###xml 155 157 155 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27">27</xref>
###xml 510 511 502 503 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1635 1636 1616 1617 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 1692 1693 1670 1671 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 2239 2241 2211 2213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28">28</xref>
###xml 2626 2628 2595 2597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21">21</xref>
###xml 1609 1615 <span type="species:ncbi:9986">rabbit</span>
###xml 1667 1673 <span type="species:ncbi:9986">rabbit</span>
###xml 1963 1967 <span type="species:ncbi:9925">goat</span>
###xml 1973 1978 <span type="species:ncbi:10090">mouse</span>
###xml 1988 1994 <span type="species:ncbi:9986">rabbit</span>
Parallel to the immunohistochemical stainings, Western blotting was performed from the frozen sections of the brain tumor biopsies as described elsewhere (27). In brief, frozen brain sections were cut in 6-microm sections and mounted on glass slides (same as for immunohistochemical stainings). Afterwards, the sections were overlaid with section lysis buffer [2% sodium dodecyl sulfate (SDS), 0.05 M dithiothreiotol, 10% glycerol, 1 mm EDTA, 16 mm Tris-HCl, pH 7.2] using a total volume of 20 microL per 10 mm2 of tissue. The solubilized tissue was collected, boiled for 10 minutes and subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis. The very small amount of tissue used in this study was not suitable for standard methods of protein measurement (eg, Bradford assay). Therefore, a protein loading control was determined separately (beta-actin, see beyond). Proteins were electrophoretically separated (New Page Gel 12%, Invitrogen, Karlsruhe, Germany) with 100 V over 24 minutes in running buffer [0.1% SDS, 1 mm EDTA, 15 mm 3-(N-morpholino) propansulphonic acid (MOPS), 50 mmol Tris-HCl, pH 7.2]. After that, the proteins were transferred to a polyvinyldifluoride (PVDF) membrane (0.45 microm, Immobilon, Millipore, Eschborn, Germany) by a semidry blotting technique with freshly prepared blotting buffer (20% methanol, 192 mmol glycin, 25 mmol Tris-base, pH 8.3). Next, the PVDF membranes were blocked in blocking buffer (0.05% w/v casein, 0.5% v/v Tween in phosphate buffer saline, pH 7.4) over 1 h at room temperature. The primary antibodies against integrin subunits (polyclonal rabbit anti-integrin alphav subunit AB1930 and polyclonal rabbit anti-integrin beta3 subunit AB1932; Chemicon, Temecula, CA, USA) were diluted in the respective blocking buffer (1:1000) and incubated overnight at 4degreesC. After a washing step, bound antibodies were labeled using a secondary antibody coupled to alkaline phosphatase (1:2000 polyclonal goat anti-mouse and anti-rabbit immunoglobulin/AP, DakoCytomation, Hamburg, Germany) over 45 minutes. Visualization followed a second washing step using chromogen nitroblue tetrazolium (NBT) salt and 5-bromo-4-chloro-3-indulylphosphate (BCIP) according to standard protocols (28). The wet blots were scanned using a high-resolution flatbed scanner before reprobing. For the detection of the endothelial component, the blots were reprobed with anti-CD31 (CD31); for the assessment of the amount of tissue, Western blots were reprobed with anti-beta-actin (Actin I-19, Santa Cruz Biotechnology, Heidelberg, Germany) as the ubiquitous component of the cytoskeleton (21). Densitometric measurements were performed with the software TotalLab V 2.01 (Nonlinear Dynamics, Newcastle upon Tyne, UK) by using series of dilution for calibration of the concentration and a protein ladder (Invitrogen, Karlsruhe, Germany) for the calibration of the molecular weights.
###end p 23
###begin title 24
PCR
###end title 24
###begin p 25
###xml 66 67 62 63 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 76 77 69 70 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 659 660 646 647 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 843 844 827 828 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 143 151 <span type="species:ncbi:9606">patients</span>
For the analysis of the mRNA expression of integrin subunits alphav and beta3, equal amounts of tumor tissue from GBMs (n = 5) and LGG (n = 3) patients were homogenized and suspended in TRIZOL(R) reagent (Invitrogen, Karlsruhe, Germany). RNA was isolated according to the manufacturer's instructions (Invitrogen, Karlsruhe, Germany). The first-strand cDNA synthesis was done by MMLV-RT (New England Biolabs, Frankfurt, Germany). Primers were designed according to the sequences of ITAV [accession number NM_002210; forward primer (2692-2716): 5'-CTATGAGCTGAGAAACAATGGTCC-3'; reverse primer (3351-3373): 5'-GCTGCTCCCTTTCTTGTTCTTC-3'] for integrin subunit alphav and ITB3 [accession number NM_00212; forward primer (1859-1881): 5'-CTGTATCCAGCCGGGCTCCTATG-3'; reverse primer (2346-2369): 5'-GCCCCGGTACGTGATATT GGTGAA-3'] for integrin subunit beta3. The analysis and comparison of the sequences were performed with the DNAstar software (GATC Biotech, Konstanz, Germany). All primers were blasted against the www-databases. PCR for amplifying total cDNA as the template was performed for up to 30 cycles with denaturation for 30 s at 95degreesC, annealing for 45 s at 64degreesC and elongation for 60 s at 72degreesC with the Advantagetrade mark 2 PCR Enzyme Systems (Takara, Otsu, Japan).
###end p 25
###begin title 26
Statistics
###end title 26
###begin p 27
###xml 197 198 197 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
Staining intensities and densities of immunopositive structures as well as densitometric measurements of the Western blots were tested for normal distribution and groups were compared by Student's t-test for unpaired values and unequal variances. All values were given with standard deviation.
###end p 27
###begin title 28
RESULTS
###end title 28
###begin title 29
###xml 30 31 26 27 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 35 36 28 29 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
Two types of patterns of alphavbeta3 and CD31 expression
###end title 29
###begin p 30
###xml 37 38 33 34 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 42 43 35 36 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 197 198 186 187 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 202 203 188 189 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 301 302 283 284 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 306 307 285 286 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 561 570 540 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Figure 1A</xref>
###xml 572 583 551 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Figure 1C,D</xref>
###xml 759 760 734 735 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 764 765 736 737 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 785 794 757 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Figure 1C</xref>
###xml 977 986 949 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Figure 1D</xref>
###xml 1146 1147 1114 1115 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 1151 1152 1116 1117 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1242 1243 1203 1204 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 1247 1248 1205 1206 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1391 1392 1345 1346 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 1396 1397 1347 1348 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1419 1428 1370 1379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Figure 1B</xref>
###xml 1561 1562 1508 1509 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 1566 1567 1510 1511 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1753 1754 1693 1694 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 1758 1759 1695 1696 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1902 1911 1839 1848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Figure 2B</xref>
Immunohistochemical staining of alphavbeta3 integrin was investigated in sections of GBMs (n = 12), diffuse low-grade astrocytomas (n = 4) as well as non-CNS tumors (n = 5). The expression of alphavbeta3 integrin was found in the microvessels as well as in the glial tumor cells. The majority of alphavbeta3 expression in glial tumors was located in samples from GBMs, which are characterized by extensive proliferation of pleomorphic glial cells accompanied by microvascular proliferates with branching glomeruloid vessels. A sample of an HE stain is given in Figure 1A. Figure 1C,D demonstrates the immunohistochemical stainings of an area with vital tumor (left) and a hypercellular zone (mid) surrounding the necrotic areas (right). The staining for alphavbeta3 integrin, shown in Figure 1C, demonstrates a high endothelium-associated expression in this hypercellular zone. This expression is almost identical to the staining of endothelial marker CD31, as demonstrated in Figure 1D (microvascular association). Nevertheless, numerous tumor cells, especially enlarged giant pleomorphic astrocytes, show a strong immunoreactivity for the alphavbeta3 integrin, too. In other samples or areas with dense tumor growth, the expression of alphavbeta3 integrin seems to be associated to glial tumor cells as well. A typical sample is demonstrated by an overlay of fluorescent stainings of alphavbeta3 integrin and CD31 in Figure 1B. The small branched proliferating microvessels marked by CD31 in red are only partially colocalized with the expression of the alphavbeta3 integrin in green, which is predominantly located in the glial tumor cells (glial association). The nuclei are counterstained in blue. In contrast to the GBMs, a low expression of alphavbeta3 integrin is found in WHO grade II diffuse astrocytomas, where the staining was more diffuse and only barely associated with the microvessels (Figure 2B).
###end p 30
###begin p 31
###xml 27 28 27 28 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 63 64 59 60 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 68 69 61 62 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 71 72 64 65 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 81 82 74 75 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 109 110 102 103 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 163 164 156 157 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 251 252 240 241 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 256 257 242 243 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 259 260 245 246 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 391 392 377 378 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 408 409 390 391 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 413 414 392 393 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 584 585 563 564 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 623 624 598 599 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 628 629 600 601 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
Hematoxilin & Eosin (H&E) (A) and immunostain of integrin alphavbeta3 (C), CD31 (D) and fluorescent overlay (B) in samples of glioblastoma. Standard H&E staining (A) shows typical morphology of a malignant glioma. Immunohistochemical staining of alphavbeta3 (C) is intense in vascular structures (asterisk) as confirmed by a consecutive section stained for the endothelial cell marker CD31 (D). Rather, alphavbeta3 is clearly detectable throughout the whole section as expressed by the glial tumor cells (arrow). A fluorescent overlay picture of another area with dense tumor growth (B) demonstrates that the integrin alphavbeta3 (green) is not restricted to vascular structures (red, asterisk) but shows a ubiquitous distribution pattern (cell nuclei blue). Scale bars: 100 microm. Abbreviations: EP = endothelial proliferation; M = mitosis.
###end p 31
###begin p 32
###xml 18 19 14 15 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 23 24 16 17 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 48 49 41 42 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 68 69 61 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 115 116 108 109 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 117 118 110 111 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 143 144 136 137 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 187 188 176 177 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 192 193 178 179 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 236 237 222 223 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 514 515 500 501 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 591 592 577 578 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
Detection of alphavbeta3 integrin in malignant (A) and a low-grade (B) glioma and analysis by an imaging software (C,D). The malignant glioma (A) exhibit a much higher expression of alphavbeta3 integrin (red) than the low-grade glioma (B), where only very few glial cells are immunopositive for the integrin. The detection of the staining intensity in the malignant glioma shows a large overall baseline (red) expression with certain strong (yellow) or even intense (white) expression in microvascular structures (C). In contrast, only some red dots can be detected in the low-grade glioma (D). Scale bars: 100 microm
###end p 32
###begin title 33
###xml 5 6 1 2 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 10 11 3 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
alphavbeta3 Protein expression is associated with malignancy
###end title 33
###begin p 34
###xml 59 60 55 56 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 64 65 57 58 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 76 87 69 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Figure 2A,B</xref>
###xml 127 138 120 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Figure 2C,D</xref>
###xml 237 238 226 227 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 242 243 228 229 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 314 315 296 297 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 319 320 298 299 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 377 378 352 353 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 382 383 354 355 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 493 494 461 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 503 512 471 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig03">Figure 3A</xref>
###xml 591 592 557 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 194 199 <span type="species:ncbi:9606">human</span>
The different samples were simultaneously stained for alphavbeta3 integrin (Figure 2A,B) and analyzed via an imaging software (Figure 2C,D). The measurements were calibrated to xenotransplanted human melanoma cells (M21) expressing alphavbeta3. These acted as a positive control and were set to 100% integrin alphavbeta3 expression. The overall mean staining intensity of alphavbeta3 integrin in GBMs reached 76.53 +/- 12.08%, which was significantly higher than in LGGs with 58.43 +/- 2.30% (P < 0.05, Figure 3A). In comparison, the samples of the non-CNS tumors reached 85.18 +/- 11.95%, (P < 0.05).
###end p 34
###begin p 35
###xml 33 34 29 30 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 38 39 31 32 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 0 165 0 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Statistical analysis of the &#945;<sub>v</sub>&#946;<sub>3</sub> integrin immunohistochemistry in patients with glioblastomas (GBMs) and low-grade gliomas (LGGs) and non-CNS tumors (non-CNS)</italic>
###xml 167 169 160 162 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A.</bold>
###xml 228 230 221 223 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B.</bold>
###xml 302 304 295 297 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C.</bold>
###xml 368 370 361 363 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D.</bold>
###xml 488 489 481 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 508 509 501 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 73 81 <span type="species:ncbi:9606">patients</span>
Statistical analysis of the alphavbeta3 integrin immunohistochemistry in patients with glioblastomas (GBMs) and low-grade gliomas (LGGs) and non-CNS tumors (non-CNS). A. Mean staining intensity of non-CNS tumors, GBMs and LGGs. B. Fraction of mild, moderate and strong stained tissue in GBMs and LGGs. C. Mean staining intensity of glial tissue only in GBMs and LGGs. D. Fraction of mild, moderate and strong stained tissue of glial tissue only in GBMs and LGGs. Significant differences (P < 0.05, Student's t-test) are indicated with an asterisk.
###end p 35
###begin p 36
###xml 195 196 191 192 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 200 201 193 194 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 248 259 241 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Figure 2C,D</xref>
###xml 412 413 401 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 432 433 421 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 440 449 429 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig03">Figure 3B</xref>
###xml 482 483 467 468 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 487 488 469 470 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 623 624 601 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 643 644 621 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 730 739 706 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig03">Figure 3B</xref>
###xml 770 771 742 743 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 775 776 744 745 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 818 819 783 784 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 823 824 785 786 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 930 931 888 889 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 935 936 890 891 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
To investigate the expression pattern in more detail, the fraction of immunohistochemically positive structures (density) were calculated for mild, moderate and strong positive detection of alphavbeta3 integrin (demonstrated by different colors in Figure 2C,D). In the samples of GBMs, 54.62 +/- 23.52% of all tissue were found at least mildly stained, whereas the samples of LGGs reached only 22.20 +/- 14.99% (P < 0.05, Student's t-test; Figure 3B). The moderate staining of alphavbeta3 integrin was nearly exclusively associated with malignancy, with 9.07 +/- 9.25% in GBMs and 0.06 +/- 0.07% in low-grade astrocytomas (P < 0.05, Student's t-test). The strong staining intensities were restricted to GBMs only (2.83 +/- 4.08%; Figure 3B). Therefore, the average alphavbeta3 integrin expression in GBMs exceeds alphavbeta3 integrin expression in LGGs by far. However, different GBMs show a very heterogeneous expression of alphavbeta3 integrin, which ranges from slightly to very strong integrin expression, similar to high expressing non-CNS tumors.
###end p 36
###begin title 37
###xml 46 47 42 43 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 51 52 44 45 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
Glioma cells substantially contribute to alphavbeta3 integrin expression
###end title 37
###begin p 38
###xml 39 40 35 36 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 44 45 37 38 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 302 303 291 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 575 576 554 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 735 736 710 711 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 740 741 712 713 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
To access the glial cell specific alphavbeta3 integrin expression within the tumor, small areas were selected and analyzed where no endothelial structures were present. These areas showed once more a significantly higher mean staining intensity in GBMs (69.47 +/- 9.49%) than in LGGs (56.41 +/- 6.83%; P < 0.05). The density of immunohistochemically positive tumor cells was measured in GBMs (mild: 46.31 +/- 22.23%, moderate: 2.02 +/- 2.88%, strong: 0.23 +/- 0.49%) and LGGs (mild: 12.31 +/- 5.46%, moderate: 0.01 +/- 0.01%, strong: 0%), which were significantly different (P < 0.05), although the smaller areas might increase the sampling error. The latter findings indicate that the tumor cells contribute substantially to the alphavbeta3 integrin expression.
###end p 38
###begin p 39
###xml 61 62 57 58 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 66 67 59 60 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 261 262 250 251 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 266 267 252 253 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
In conclusion, GBMs demonstrated a higher expression of alphavbeta3 integrin than low-grade astrocytomas that was not only caused by a high focal reactivity in proliferating microvessels but also by stronger expression in glial tumor cells. The pattern of alphavbeta3 integrin expression depended also on the subtype of tumor. In malignant gliomas, more than three quarters of the overall integrin expression (about 85%) is derived from glial tumor cells.
###end p 39
###begin title 40
###xml 4 5 1 2 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
beta3 Integrin subunit expression shows an essential difference between GBMs and LGGs in Western blot analysis
###end title 40
###begin p 41
###xml 67 68 63 64 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 72 73 65 66 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 260 261 253 254 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 346 347 336 337 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 363 364 349 350 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 468 469 451 452 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 630 631 609 610 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 791 792 766 767 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 836 837 807 808 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 890 899 861 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig04">Figure 4A</xref>
###xml 1113 1114 1078 1079 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1152 1153 1113 1114 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 1276 1277 1234 1235 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 965 973 <span type="species:ncbi:9606">patients</span>
To investigate the immunohistochemical expression of integrin alphavbeta3 expression in more detail, we performed Western blot analysis from frozen brain tumor samples as described in the methods. Each lane was loaded with an equal tissue volume of 30 nL (5 mm2 of tissue). The Western blots were incubated with subunit specific antibody for beta3 chain and alphav chains. Thereby, the integrin subunits demonstrate degradation to potential cleavage products. The beta3 chains were detected as weak bands at a molecular weight of about 96 kDa accompanied by their major degradation products at about 64 and 52 kDa. The heavy alphav chains were detectable at 137 kDa. Further on, strong double bands were detectable at about 25 and 27 kDa, which correspond to major degradation products alphav light chains. The full lengths of the alphav light chains are barely detectable at about 52 kDa. Figure 4A shows the detection of integrin subunits from five different GBM patients (left five lanes; the one lane on the right demonstrates CD31 and beta-actin). The group of GBMs demonstrate a heterogenous pattern of beta3 chains, whereas the portions of alphav light chains were strongly present in all samples. The expression in low-grade astrocytomas was lower, especially the beta3 chains, which were barely detectable.
###end p 41
###begin p 42
###xml 71 72 67 68 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 76 77 69 70 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 167 168 160 161 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 231 232 224 225 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 289 290 278 279 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 305 306 290 291 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 473 474 436 437 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 565 566 505 506 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 575 576 512 513 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 812 814 689 691 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B.</bold>
###xml 883 884 757 758 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 949 950 823 824 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 969 970 843 844 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1015 1016 885 886 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 1076 1077 942 943 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
Western blot analysis of subunits and degradation products of the alphavbeta3 integrin. The Western blot analysis of five different glioblastoma (GBM) tissue samples (A, left lanes) and densitometric analysis of integrin subunits (B). In all glial tumors, degradation products of the alphav subunit (alphav light chains) were detected as a double band at 25/27 kDa (black triangle right). Expression was constantly present but heterogeneous between different GBMs. The beta3 subunit was detected at about 96 kDa (black triangle right). Degradation products of alphav and beta3 subunit were found at 55 kDa (black triangle right). The detection of CD31 at about 80 kDa (right black triangle right) and beta-actin at about 42 kDa (right black triangle right) is additionally demonstrated in the lane on the right. B. Densitometric analysis revealed significant differences for the beta3 subunit between malignant gliomas and low-grade gliomas (LGGs) (P < 0.05; Student's t-test; indicated with an asterisk). The alphav subunit (about 137 kDa) and its degradation products (alphav light chains, 25/27 kDa) showed no significant differences between high- and low-grade gliomas.
###end p 42
###begin p 43
###xml 28 37 28 37 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig04">Figure 4B</xref>
###xml 146 147 143 144 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 173 174 166 167 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 410 411 396 397 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 550 551 532 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 570 571 552 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 578 585 560 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 612 613 590 591 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
The densitometric analysis (Figure 4B) of the samples, calibrated by the dilution series of a reference probe, revealed an overall density of beta3 chain at 96 kDa and alphav light chains at 25 and 27 kDa of 102.8 +/- 43.0 in GBMs (n = 20) and 69.1 +/- 30.9 in low-grade astrocytomas (n = 5), which corroborates the immunohistochemical measurements (but is not statistically significant). By comparing the beta3 subunit at 96 kDa, we found a highly significantly elevated expression in GBMs with 6.18 +/- 4.59 compared with LGGs with 1.07 +/- 0.549 (P < 0.05; Student's t-test, Table 1). The expressions of alphav light chains at 25 and 27 kDa were not significantly different in GBMs (51.6 +/- 23.0 and 45.0 +/- 19.9 respectively) and in low-grade astrocytomas (43.4 +/- 35.6 and 24.6 +/- 24.6, respectively).
###end p 43
###begin p 44
###xml 49 50 45 46 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 59 60 52 53 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 208 209 197 198 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 230 231 216 217 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 420 421 403 404 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 503 504 486 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 523 524 506 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
Densitometric analysis of integrin subunits alphav and beta3 and microvascularization in glioblastomas (GBMs), low-grade gliomas (LGGs) and non-CNS tumors (non-CNS). Overall density of integrin subunits alphav (25/27 kDa) and beta3 (96 kDa) as well as the endothelial cells (CD31; 80 kDa) of the tumors was assessed by the Western blot analysis and calibrated by a dilution series of a reference probe. In GBMs, the beta3 subunit at 96 kDa showed a significantly elevated expression compared with LGGs (P < 0.05; Student's t-test). The amount of CD31 demonstrated quite different values in GBMs and in LGGs, indicating microvascular proliferation.
###end p 44
###begin p 45
###xml 141 150 141 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig04">Figure 4A</xref>
###xml 308 309 304 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 358 359 350 351 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 363 364 352 353 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 626 627 607 608 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 631 632 609 610 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 651 658 629 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 757 758 731 732 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 762 763 733 734 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
Further on, microvascularization was assessed by Western blot analysis using the endothelial cell marker CD31, which was detected at 80 kDa (Figure 4A, right lane). Densitometric analysis demonstrated that samples of GBMs had significantly higher staining intensities (25.2 +/- 12.9) than LGGs (4.9 +/- 2.2, P < 0.05). The ratio of the overall integrin alphavbeta3 detection (sum GBMs 102.8 +/- 43.0, sum LGGs 69.1 +/- 30.9) to the amount of CD31 demonstrated quite different values of 4.1 in GBMs and 14.1 in LGGs, which indicates that the detection of CD31 positive endothelial cells overcomes the higher expression of alphavbeta3 integrin in GBMs (Table 1). Consequently, the numerous proliferating endothelial cells do not contribute at all to the alphavbeta3 integrin expression.
###end p 45
###begin title 46
###xml 23 24 19 20 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 38 39 31 32 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
Integrin subunits alphav mRNA and beta3 mRNA both found in GBMs and low-grade astrocytomas
###end title 46
###begin p 47
###xml 76 77 72 73 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 81 82 74 75 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 320 328 313 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig05">Figure 5</xref>
###xml 416 417 405 406 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 426 427 412 413 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 513 514 495 496 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 595 596 574 575 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 785 786 760 761 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 790 791 762 763 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
As immunohistochemical stainings and Western blot analysis revealed an alphavbeta3 integrin expression in malignant GBMs and in a low level in low-grade astrocytomas, we investigated the expression on mRNA level. Cryoconserved tissue of low- and high-grade gliomas was subjected to RT-PCR as described in the materials. Figure 5 demonstrates the PCR product after 24 to 36 recombination cycles for the subunits alphav and beta3 in a sample of a malignant GBM and a low-grade astrocytoma. The mRNA of subunit alphav was strongly amplified in both high- and low-grade gliomas. The mRNA of the beta3 subunit was also present in both tumor entities but amplified on a lower level. Therefore, on the mRNA level, both malignant GBM and low-grade astrocytoma were able to express active alphavbeta3 integrin, as suggested by the previous immunohistochemistry and Western blotting, which corroborates the previous results of immunohistochemistry and Western blotting.
###end p 47
###begin p 48
###xml 21 22 17 18 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 26 27 19 20 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 68 69 57 58 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 73 74 59 60 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 98 99 80 81 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 101 102 83 84 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 103 104 85 86 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 114 115 93 94 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 116 117 95 96 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 118 119 97 98 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 145 146 124 125 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 147 148 126 127 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 177 178 156 157 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 179 180 158 159 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 378 379 353 354 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 397 398 369 370 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 544 545 512 513 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 549 550 514 515 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
PCR analysis of alphavbeta3 integrin subunits. PCR analysis of alphavbeta3 integrin subunits alphav (A,B) and beta3(C,D) of a glioblastoma (GBM; A,C) and low-grade glioma (LGG; B,D) after different recombination cycles. Lane 1: 24 cycles, lane 2: 27 cycles, lane 3: 30 cycles, lane 4: 33 cycles and lane 5: 36 recombination cycles. Standard PCR revealed that both subunits alphav (690 bp) and beta3 (510 bp) are synthesized in high as well as low-grade gliomas indicating that both tumor entities are able to express a functionally active alphavbeta3 integrin receptor. Marker (M) was a 50 bp ladder (Novagen, Perfect DNA ladder).
###end p 48
###begin title 49
DISCUSSION
###end title 49
###begin p 50
###xml 157 158 157 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 160 162 160 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23">23</xref>
###xml 164 166 164 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">31</xref>
###xml 168 170 168 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b39">39</xref>
###xml 257 258 253 254 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 262 263 255 256 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 413 414 402 403 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 418 419 404 405 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 532 534 518 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">16</xref>
###xml 535 537 521 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">18</xref>
###xml 539 541 525 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b38">38</xref>
###xml 544 551 530 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In situ</italic>
###xml 605 606 587 588 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 615 616 594 595 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 663 664 638 639 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 668 669 640 641 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 719 721 691 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">16</xref>
###xml 723 725 695 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b38">38</xref>
###xml 827 828 795 796 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 837 838 802 803 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 839 841 804 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32">32</xref>
###xml 865 870 830 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 925 926 886 887 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 930 931 888 889 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1001 1002 959 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 1087 1088 1041 1042 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 1092 1093 1043 1044 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1154 1155 1105 1106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">7</xref>
###xml 1157 1158 1108 1109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">9</xref>
###xml 1160 1162 1111 1113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29">29</xref>
###xml 1164 1166 1115 1117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b38">38</xref>
###xml 1272 1273 1219 1220 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 1277 1278 1221 1222 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1358 1359 1298 1299 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 1363 1364 1300 1301 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
Integrins are adhesion receptors that mediate cell-cell as well as cell-ECM interactions associated with tumor growth and angiogenesis in malignant gliomas (5, 23, 31, 39). However, there is still a controversy about the extent and the distribution of alphavbeta3 integrin expression caused by malignancy and the cell type of origin in gliomas. In literature, 30% of glioma cells were described positive for alphavbeta3 integrin in anaplastic astrocytomas and GBMs, whereas LGGs did not express detectable amounts of this integrin (16-18, 38). In situ studies for the two different integrin subunits alphav and beta3 revealed that the expression of integrin alphavbeta3 was focused more on small blood vessels of GBMs (16, 38). One other group detected individual glial tumor cells of GBMs to be positive for the subunits alphav and beta3(32). Only recently, Bello et al reported a more prominent expression of integrin alphavbeta3 on glioma cells but without providing a detailed expression pattern (5). Yet, this is a matter of major interest for therapeutic delivery of integrin alphavbeta3 interfering agents to reduce tumor angiogenesis and growth (7, 9, 29, 38). The efficacy of this approach is clearly dependent on the intratumoral extent and distribution of alphavbeta3 integrin, as it has to be supposed that mainly the endothelial cell bound alphavbeta3 integrin portion is reached by intravenous application.
###end p 50
###begin p 51
###xml 72 73 68 69 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 77 78 70 71 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 395 396 384 385 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 400 401 386 387 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 685 686 667 668 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 690 691 669 670 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 829 830 804 805 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 834 835 806 807 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 853 854 825 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 856 858 828 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">16</xref>
###xml 1004 1005 972 973 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 1009 1010 974 975 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1099 1100 1060 1061 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 1104 1105 1062 1063 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1131 1133 1089 1091 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">18</xref>
For this reasons, the extent, distribution and pattern of integrin alphavbeta3 expression as well as its correlation to tumor grade were investigated. The computed immunohistochemistry and calibrated staining analysis provided high accuracy and the possibility to bypass the very crucial point of visual quantification of immunohistochemical staining results. In GBMs, a high expression of alphavbeta3 integrin was found not only in the endothelial cells of proliferating microvessels but also in tumor cells. The great variability of the expression might, in part, explain why the studies that have been carried out so far showed controversial results according to the amount of alphavbeta3 integrin and its cellular and regional distribution within the tumor. While previous reports focused more on the impact of integrin alphavbeta3 on angiogenesis (5, 16), we demonstrated that glial tumor cells themselves contribute significantly, accounting for approximately 85% of the overall expression of alphavbeta3 integrin. In contradiction to former studies, we were also able to detect integrin alphavbeta3 expression even in LGGs (18), but on a significantly lower level and predominantly on tumor cells, as there is a lower vascularization.
###end p 51
###begin p 52
###xml 123 124 120 121 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 173 174 166 167 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 213 215 206 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">12</xref>
###xml 336 337 325 326 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 374 375 360 361 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 401 402 383 384 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 406 407 385 386 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 483 484 462 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 532 533 505 506 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 539 540 509 510 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 546 547 513 514 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sub>
###xml 583 584 546 547 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 610 611 570 571 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 660 661 616 617 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 676 679 628 631 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 697 698 649 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 700 702 652 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">18</xref>
###xml 704 706 656 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23">23</xref>
###xml 708 710 660 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">24</xref>
###xml 712 714 664 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32">32</xref>
###xml 763 764 711 712 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 768 769 713 714 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 894 895 836 837 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1015 1016 957 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 1018 1020 960 962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">16</xref>
###xml 1022 1024 964 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">18</xref>
###xml 1051 1052 989 990 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 1056 1057 991 992 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1249 1250 1184 1185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 1252 1253 1187 1188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8">8</xref>
###xml 1255 1256 1190 1191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">9</xref>
###xml 1258 1260 1193 1195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b11">11</xref>
###xml 1262 1264 1197 1199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b37">37</xref>
###xml 1401 1402 1332 1333 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 1406 1407 1334 1335 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1472 1474 1400 1402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30">30</xref>
###xml 1582 1583 1506 1507 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 1587 1588 1508 1509 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1754 1755 1675 1676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">1</xref>
###xml 1757 1759 1678 1680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">22</xref>
###xml 1761 1763 1682 1684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35">35</xref>
###xml 1524 1529 <span type="species:ncbi:10090">mouse</span>
###xml 1653 1657 <span type="species:ncbi:10090">mice</span>
Interestingly, our miniaturized Western blot analysis revealed a significant difference only for the expression of the beta3 subunit between GBMs and LGGs, whereas the alphav subunit and its degradation products (12) showed no significant difference between these tumor entities. This might be caused by the fact that the integrin alphav subunit is also needed with the beta5 subunit to form the alphavbeta5 integrin, which is also abundant in highly vascularized malignant gliomas (5). Moreover, there are other beta subunits (beta1, beta6, beta8) that heterodimerize with the alphav subunit, whereas the beta3 subunit in brain tumors only partners with alphav and with alphaIIb in thrombocytes (5, 18, 23, 24, 32). Therefore, the endothelial expression of alphavbeta3 integrin seems to be characteristic for malignant microvessel transformation, as it has already been described that the beta3 subunit expression in GBMs is most prominent in endothelial and perivascular cells associated with tumor angiogenesis (5, 16, 18). Moreover, integrin alphavbeta3 has already been detected in colocalization with MMP-2, where it was found to correlate with the dedifferentiation and invasive behavior of invasive endothelial cells as well as tumor cells (5, 8, 9, 11, 37). As MMP-2 is an important metalloproteinase for the invasion and dissemination of tumor cells, its functional relationship to the alphavbeta3 integrin expression might play a key role in tumor progression (30). However, recent studies on genetically altered mouse models raise the question whether the integrin alphavbeta3 is truly proangiogenic and necessary for tumor angiogenesis, as mice lacking either one of these subunits are viable and fertile and show extensive vascularization (1, 22, 35).
###end p 52
###begin p 53
###xml 84 85 80 81 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 89 90 82 83 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 239 240 228 229 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 244 245 230 231 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 416 417 398 399 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 421 422 400 401 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 641 642 616 617 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 646 647 618 619 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 760 761 728 729 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 765 766 730 731 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 824 825 789 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2">2</xref>
###xml 826 827 791 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">4</xref>
###xml 829 831 794 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19">19</xref>
###xml 833 835 798 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20">20</xref>
###xml 837 839 802 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30">30</xref>
###xml 998 999 959 960 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 1003 1004 961 962 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 151 159 <span type="species:ncbi:9606">patients</span>
###xml 311 319 <span type="species:ncbi:9606">patients</span>
###xml 568 575 <span type="species:ncbi:9606">patient</span>
Despite these still unanswered questions, antiangiogenic therapy with integrin alphavbeta3 antagonists has reached clinical phase I/IIa trials for the patients with malignant gliomas. Therefore, minute detection and quantification of alphavbeta3 integrin expression could be a prerequisite for the selection of patients suitable for this kind of additional therapy to analyze the potential relationship between alphavbeta3 expression and antitumor activity. In the context of a modern personalized cancer therapy, the benefits should be calculated for each individual patient, especially, as GBMs show a very heterogenous expression of alphavbeta3 integrin, which ranges from only mild to very strong. This might also include the noninvasive detection of alphavbeta3 expression in gliomas through molecular imaging methods (2-4, 19, 20, 30). Thus, future studies will have to confirm that either tumor angiogenesis or higher malignancy in gliomas in fact correlate with the amount of integrin alphavbeta3 expression. This could also lead to new diagnostic and therapeutic approaches for integrin-interfering agents.
###end p 53
###begin p 54
We thank Gertrud Kwiatkowski, Angelika Henn and Stefanie Lange for excellent technical work on tissue preparation, immunohistochemistry and PCR. We thank Dorothee Rieger for proofreading this manuscript.
###end p 54
###begin p 55
This study was supported by a grant from the Forderprogramm fur Forschung und Lehre of the Faculty of Medicine of the Ludwig-Maximilians-Universitat Munchen (O.S.; FoFoLe, Reg. No. 377) and from the Deutsche Forschungsgemeinschaft (C.G.; DFG-Forschergruppe Radionuklidtherapie, FOR-411).
###end p 55
###begin title 56
REFERENCES
###end title 56
###begin article-title 57
###xml 79 83 <span type="species:ncbi:10090">mice</span>
Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all alpha v integrins
###end article-title 57
###begin article-title 58
Molecular imaging with new
###end article-title 58
###begin article-title 59
PET tracers
###end article-title 59
###begin article-title 60
###xml 99 107 <span type="species:ncbi:9606">patients</span>
Biodistribution and pharmacokinetics of the alphavbeta3-selective tracer 18F-galacto-RGD in cancer patients
###end article-title 60
###begin article-title 61
###xml 114 117 <span type="species:ncbi:9606">man</span>
Positron emission tomography using [18F] Galacto-RGD identifies the level of integrin alpha(v)beta3 expression in man
###end article-title 61
###begin article-title 62
Alpha(v)beta3 and alpha(v)beta5 integrin expression in glioma periphery
###end article-title 62
###begin article-title 63
Simultaneous inhibition of glioma angiogenesis
###end article-title 63
###begin article-title 64
###xml 70 75 <span type="species:ncbi:9606">human</span>
cell proliferation, and invasion by a naturally occurring fragment of human metalloproteinase-2
###end article-title 64
###begin article-title 65
IS20I, a specific alphavbeta3 integrin inhibitor, reduces glioma growth in vivo
###end article-title 65
###begin article-title 66
Identification of a novel class of small-molecule antiangiogenic agents through the screening of combinatorial libraries which function by inhibiting the binding and localization of proteinase MMP2 to integrin alpha(V)beta(3)
###end article-title 66
###begin article-title 67
Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
###end article-title 67
###begin article-title 68
###xml 35 40 <span type="species:ncbi:9606">human</span>
###xml 82 87 <span type="species:ncbi:9606">human</span>
Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin
###end article-title 68
###begin article-title 69
Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3
###end article-title 69
###begin article-title 70
###xml 87 92 <span type="species:ncbi:9606">human</span>
Biosynthetic and functional properties of an Arg-Gly-Asp-directed receptor involved in human melanoma cell attachment to vitronectin, fibrinogen, and von Willebrand factor
###end article-title 70
###begin article-title 71
Integrin-mediated death: an explanation of the integrin-knockout phenotype?
###end article-title 71
###begin article-title 72
Molecular mechanisms of glioma cell migration and invasion
###end article-title 72
###begin article-title 73
Definition of two angiogenic pathways by distinct alpha v integrins
###end article-title 73
###begin article-title 74
Expression of integrin alpha v beta 3 in small blood vessels of glioblastoma tumors
###end article-title 74
###begin article-title 75
Glioblastoma expression of vitronectin and the alpha v beta 3 integrin. Adhesion mechanism for transformed glial cells
###end article-title 75
###begin article-title 76
Cerebral microenvironment influences expression of the vitronectin gene in astrocytic tumors
###end article-title 76
###begin article-title 77
Radiolabeled alpha(v)beta3 integrin antagonists: a new class of tracers for tumor targeting
###end article-title 77
###begin article-title 78
###xml 74 82 <span type="species:ncbi:9606">patients</span>
Noninvasive visualization of the activated alphavbeta3 integrin in cancer patients by positron emission tomography and [18F]Galacto-RGD
###end article-title 78
###begin article-title 79
Actin isoforms
###end article-title 79
###begin article-title 80
###xml 25 29 <span type="species:ncbi:10090">mice</span>
Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival
###end article-title 80
###begin article-title 81
Integrins: versatility, modulation, and signaling in cell adhesion
###end article-title 81
###begin article-title 82
A reevaluation of integrins as regulators of angiogenesis
###end article-title 82
###begin article-title 83
The WHO classification of tumors of the nervous system
###end article-title 83
###begin article-title 84
A method to perform Western blots of microscopic areas of histological sections
###end article-title 84
###begin article-title 85
Rapid and sensitive colorimetric method for visualizing biotin-labeled DNA probes hybridized to DNA or RNA immobilized on nitrocellulose: bio-blots
###end article-title 85
###begin article-title 86
Preferential susceptibility of brain tumors to the antiangiogenic effects of an alpha(v) integrin antagonist
###end article-title 86
###begin article-title 87
Expression of matrix metalloproteinases and their inhibitors in medulloblastomas and their prognostic relevance
###end article-title 87
###begin article-title 88
Interactions of glioma cells and extracellular matrix
###end article-title 88
###begin article-title 89
###xml 64 69 <span type="species:ncbi:9606">human</span>
Characterization of integrin receptors in normal and neoplastic human brain
###end article-title 89
###begin article-title 90
Synapse formation and function is modulated by the amyloid precursor protein
###end article-title 90
###begin article-title 91
Pathology and classification of tumors of the nervous system
###end article-title 91
###begin article-title 92
###xml 38 42 <span type="species:ncbi:10090">mice</span>
Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins
###end article-title 92
###begin article-title 93
Integrins
###end article-title 93
###begin article-title 94
Disruption of matrix metalloproteinase 2 binding to integrin alpha vbeta 3 by an organic molecule inhibits angiogenesis and tumor growth in vivo
###end article-title 94
###begin article-title 95
Alpha v-Integrin antagonist EMD 121974 induces apoptosis in brain tumor cells growing on vitronectin and tenascin
###end article-title 95
###begin article-title 96
Tissue factor, osteopontin, alphavbeta3 integrin expression in microvasculature of gliomas associated with vascular endothelial growth factor expression
###end article-title 96
###begin article-title 97
The role of the extracellular matrix in angiogenesis in malignant glioma tumors
###end article-title 97
###begin article-title 98
Crystal structure of the extracellular segment of integrin alpha Vbeta3
###end article-title 98

